Form 4: Myomo CFO Acquires RSUs, Sells Shares for Taxes

Myomo, Inc. Chief Financial Officer David A. Henry received a grant of Restricted Stock Units and subsequently sold shares to cover tax obligations.

Summary

• David A. Henry, Chief Financial Officer of Myomo, Inc., was granted 12,500 Restricted Stock Units (RSUs) on April 10, 2026.
• These RSUs were granted under a program where employees can exchange 10% of their salary for RSUs valued at 115% of the exchanged salary.
• This specific grant represents the exchange of three months of salary.
• The RSUs vest in their entirety on July 9, 2026.
• On April 13, 2026, Henry sold 3,953 shares for $0.71 per share.
• These shares were sold to cover income taxes resulting from the vesting of restricted stock units on April 12, 2026.
• The sale was executed based on an irrevocable election made by Henry on December 11, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details standard executive compensation and tax-related share sales rather than significant strategic shifts or performance indicators.

Positives

• Grant of 12,500 RSUs indicates a form of equity-based compensation and potential future value for the CFO.
• The RSU program allows employees to defer salary into equity, potentially aligning employee and shareholder interests.
• The sale of shares was pre-planned via an irrevocable election, suggesting a structured approach to managing tax liabilities.

Negatives

• The sale of shares, even for tax purposes, represents a reduction in the CFO's direct beneficial ownership.
• The transaction involves the CFO selling company stock, which could be perceived negatively by the market if not clearly understood as a tax-related event.

Risks

• Potential for negative market perception if the share sale is not clearly understood as a tax-related event.
• Vesting of RSUs on July 9, 2026, could lead to further share sales if tax obligations arise.

Future Outlook

The filing indicates that the granted RSUs will vest in their entirety on July 9, 2026, which may lead to future transactions related to tax obligations.

Management Comments

• The RSU grant is part of a program allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged.
• The sale of shares on April 13, 2026, was solely to pay income taxes resulting from the vesting of restricted stock units on April 12, 2026.
• The transaction was completed pursuant to an irrevocable election made by the Reporting Party on December 11, 2025.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to executive compensation like RSU grants and subsequent tax-related sales, are common in the biotechnology and medical device sectors. These filings provide transparency into how executives are compensated and manage their equity holdings.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CFO's interests with long-term company performance. The tax-related sale is a pre-planned event and should not significantly impact share price if understood correctly.
• Employees: The RSU program offers an incentive for employees to participate in the company's equity growth.
• Management: The transaction reflects standard executive compensation practices.

Next Steps

• Monitoring the vesting of RSUs on July 9, 2026.
• Observing any future transactions by David A. Henry related to his equity holdings.

Key Dates

Keywords

Myomo Inc, MYO, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Options, Executive Compensation, SEC Filing, Beneficial Ownership, David A. Henry, Chief Financial Officer